4 November 2024. Futura Medical plc ("Futura" or the "Company") Encouraging New Product Development Pipeline Results Futura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon ...

Collecting feedback helps improve new product development. Encourage customers to share honest opinions through surveys or one-on-one conversations. Focus on decisions based on data by analyzing ...

Futura Medical has released an update.Futura Medical has announced promising results from its new product development pipeline, including the successful completion of proof of concept studies for ...

Non-GAAP research and development expense for fiscal year 2025 is expected to be approximately $49 million to $52 million, of which $18 million to $20 million is expected to be for third-party ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results , with sales up 19.5% year on year to $1.05 billion. Its non-GAAP profit of $1.16 per share was 10.6% above ...

• Leadership recognizes that the engineering team that supports the product line is probably the group most knowledgeable about the product, how it's made, and its weaknesses. It would seem that this ...

The nomination of two new development candidates, MURA-8518 and MURA-7012, indicates a strategic expansion of the company’s product pipeline, enhancing its research and development potential ...

Sturm Ruger projects $20M in 2025 capital expenditures with strong new product pipeline Feb. 20, 2025 10:53 AM ET Sturm, Ruger & Company, Inc. (RGR) Stock AI-Generated Earnings Calls Insights 4 ...

New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and ...

Futura Medical (GB:FUM) has released an update.Futura Medical has announced promising results from its new product development pipeline, including the successful completion of proof of concept ...

EL DORADO HILLS, Calif., February 10, 2025--Blaize Holdings, Inc. (NASDAQ: BZAI) ("Blaize"), a provider of purpose-built, artificial intelligence (AI)-enabled edge-optimized solutions, has ...